Literature DB >> 10981034

Leptin: pathogenesis and treatment of morbid obesity.

A Kumar1, N A Inverso, C D Still.   

Abstract

Leptin is a hormone produced primarily by the adipocytes. It works through different receptors and seems to provide information to the hypothalamus about the energy status of the body. Although leptin appears to exert its anti-obesity effect through its central action, the full spectrum of its action is yet to be determined. Most obese subjects in studies have high serum levels of leptin, suggesting that the major problem is leptin resistance rather than leptin deficiency. Consequently, these patients may not respond to exogenous leptin. Recent trials have indicated, however, that leptin may have therapeutic potential in leptin-deficient as well as leptin-resistant states.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981034     DOI: 10.1007/s11894-000-0029-5

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  54 in total

Review 1.  Insulin in the brain: a hormonal regulator of energy balance.

Authors:  M W Schwartz; D P Figlewicz; D G Baskin; S C Woods; D Porte
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

Review 2.  Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity.

Authors:  G A Bray; D A York
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

3.  Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight.

Authors:  C Schubring; W Kiess; P Englaro; W Rascher; J Dötsch; S Hanitsch; A Attanasio; W F Blum
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

4.  Dexamethasone increases leptin expression in humans in vivo.

Authors:  S Papaspyrou-Rao; S H Schneider; R N Petersen; S K Fried
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

5.  Absence of soluble leptin receptor in plasma from dbPas/dbPas and other db/db mice.

Authors:  C Li; E Ioffe; N Fidahusein; E Connolly; J M Friedman
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

6.  Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion.

Authors:  W T Donahoo; D R Jensen; T J Yost; R H Eckel
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects.

Authors:  T Utriainen; R Malmström; S Mäkimattila; H Yki-Järvinen
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

Review 9.  Leptin, leptin receptors, and the control of body weight.

Authors:  J M Friedman
Journal:  Nutr Rev       Date:  1998-02       Impact factor: 7.110

10.  Leptin receptor action in hepatic cells.

Authors:  Y Wang; K K Kuropatwinski; D W White; T S Hawley; R G Hawley; L A Tartaglia; H Baumann
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.